Skip to content

Hao-Yuan Chuang, Chief Financial Officer at Belite Bio, sold BLTE on Aug 12, 2026

Data as of Oct 16

▼ SELL$40.3K223 shares at $180.57Hao-Yuan Chuang Chief Financial OfficerBLTE Belite Bio, Inc
Watch BLTE
Traded
Aug 12, 2026
Disclosed
Aug 14, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Hao-Yuan Chuang, Chief Financial Officer at Belite Bio, sold BLTE on Aug 12, 2026TRADEDDISCLOSED
BLTESimilar stocks (XLV — its sector index fund), rebased to BLTE's price on the disclosure day
BLTE since disclosure
−12.3%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHao-Yuan Chuang Chief Financial OfficerBLTE Belite Bio, Inc$25.9Kdisclosed Aug 14 · filed 2 days after the trade

See every trade on BLTE →